Zota Health Care’s Growth Analyzed

Zota Health Care, a company that makes and sells medicines, saw its stock price go up 1.56% to Rs 1,543.20. This happened because they announced they were building a lot more stores for their medicine services. They opened 276 new stores in their Davaindia locations.

Key Points

• Zota Health expanded with 276 new stores in Davaindia network.
• COCO segment grew by 231 stores to 1,207 locations total.
• FOFO segment added 45 stores, reaching 848 stores overall.
• Revenue jumped 91.7% to Rs 128.95 crore compared to last year.
• Net profit dropped 31.8% to Rs 15.95 crore in Q2 FY26.
• Zota Health operates domestically and internationally with pharmaceutical products.

The company’s two main types of stores, called COCO and FOFO, are growing quickly. The COCO segment, which has 231 new stores, now has a total of 1,207 stores. This is run by Davaindia Health Mart, which is a company completely owned by Zota Health Care.

The FOFO segment also added stores, bringing its total to 848. These stores also sell medicines.

Even though Zota Health made a lot more money (91.7% increase), their profit didn’t go up as much. Their net profit actually went down 31.8% to Rs 15.95 crore. This suggests they might be spending more money to grow their business.

Zota Health Care makes and sells medicines to people all over the world – both in India and in other countries. They are focused on growing their store network to reach more customers.

Expanding Zota Health’s reach is key to sustained financial growth.